h5G1.1-scFv Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
h5G1.1-scFv used to reduce the impact of complement-mediated injuries sustained during cardiopulmonary bypass (humanized monoclonal antibody).
h5G1.1-scFv Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte